Fidelity International’s Ionis Pharmaceuticals IONS Stock Holding History

Fidelity International’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18K	Buy	227 +62	+38%	+$4.67K	﹤0.01%	1127
2026 Q1	$12.4K	Buy	165 +118	+251%	+$9.31K	﹤0.01%	1083
2025 Q4	$3.72K	Hold	47	–	–	﹤0.01%	1016
2025 Q3	$3.08K	Buy	+47	New	+$2.29K	﹤0.01%	988
2016 Q2	–	Sell	-33,916	Closed	-$1.37M	–	506
2016 Q1	$1.37M	Sell	33,916 -2,724	-7%	-$111K	﹤0.01%	448
2015 Q4	$2.27M	Hold	36,640	–	–	0.01%	420
2015 Q3	$1.48M	Sell	36,640 -36,987	-50%	-$1.91M	0.01%	455
2015 Q2	$4.24M	Sell	73,627 -140,255	-66%	-$8.92M	0.01%	429
2015 Q1	$13.6M	Sell	213,882 -62,274	-23%	-$4.23M	0.04%	328
2014 Q4	$17.1M	Buy	+276,156	New	+$13.6M	0.06%	286

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity International's IONS Position: Q2 2026 in Review

Fidelity International increased its Ionis Pharmaceuticals (IONS) stake by 38% in Q2 2026, buying an estimated $4.67K and bringing the position to 227 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Fidelity International first reported a position in IONS in Q4 2014 and has held it in 10 quarters since. The position peaked at $17.1M in Q4 2014. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Fidelity International held 227 shares of Ionis Pharmaceuticals worth $18K as of Q2 2026.
Fidelity International bought 62 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.67K.
Ionis Pharmaceuticals made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #1127 holding.
Fidelity International first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 10 quarters since.
Fidelity International's Ionis Pharmaceuticals position peaked at $17.1M in Q4 2014.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.